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Mitochondrial respiratory dysfunction is linked to
the pathogenesis of multiple diseases, including
heart failure, but the specific mechanisms for this
link remain largely elusive. We modeled the impair-
ment of mitochondrial respiration by the inactivation
of the Ndufs4 gene, a protein critical for complex I
assembly, in the mouse heart (cKO). Although com-
plex I-supported respiration decreased by >40%,
the cKO mice maintained normal cardiac function
in vivo and high-energy phosphate content in iso-
lated perfused hearts. However, the cKO mice
developed accelerated heart failure after pressure
overload or repeated pregnancy. Decreased NAD+/
NADH ratio by complex I deficiency inhibited Sirt3
activity, leading to an increase in protein acetylation
and sensitization of the permeability transition in
mitochondria (mPTP). NAD+ precursor supplemen-
tation to cKO mice partially normalized the NAD+/
NADH ratio, protein acetylation, and mPTP sensi-
tivity. These findings describe a mechanism con-
necting mitochondrial dysfunction to the suscepti-
bility to diseases and propose a potential
therapeutic target.
INTRODUCTION
Mitochondrial dysfunction contributes to the pathogenesis of a
wide variety of common diseases, including neurodegenerative
diseases, obesity, diabetes, and cardiovascular diseases. Mito-
chondria-triggered cell death is a major cause of cardiac injury
and heart failure during cardiac stress. Studies in mitochondrial
diseases have shown that over 50% of individuals with muta-
tions in genes encoding mitochondrial proteins develop cardio-
myopathy, implicating the significance of mitochondrial defects
in the development of cardiac pathology (DiMauro and Schon,
2003). Observations from human studies on heart failure as
well as in animal models suggest that defects in mitochondrial
bioenergetics may contribute to the development and progres-Celsion of the disease. ‘‘Energy starvation’’ has been a longstand-
ing hypothesis in the pathogenesis of heart failure; multiple
defects in substrate metabolism, oxidative phosphorylation,
and energy-transfer mechanisms have been suggested (Neuba-
uer, 2007). The impairment of oxidative phosphorylation due to
dysfunction in the electron transport chain (ETC) not only
affects ATP production but also has been proposed to impair
intracellular Ca2+ flux, increase the generation of reactive oxy-
gen species (ROS), and alter redox balance because of
changes in the NAD+/NADH ratio (Grad et al., 2005; Neubauer,
2007).
The impaired function of complex I of the ETC has been
observed in several diseases, including cardiomyopathy and
heart failure (Ide et al., 1999; Marı´n-Garcı´a et al., 2009; Scheubel
et al., 2002). Complex I contains 45 different subunits, and its
main role is to transfer electrons from NADH to the ETC for
ATP synthesis. Under normal conditions, it is estimated that up
to 5% of the mitochondrial oxygen consumption can be con-
verted into ROS as a byproduct of the ETC activity, primarily
by complexes I and III (Lee and Wei, 1997). In model systems,
ETC dysfunction is often associated with increased ROS gener-
ation and cellular damage, but the antioxidant treatment is far
less effective in patients. On the other hand, cell death (both
apoptosis and necrosis) due to the abnormal opening of the
mitochondria permeability transition pore (mPTP) has been pro-
posed as a disease mechanism in multiple diseases, including
heart failure (Elrod et al., 2010; Halestrap, 2010; Millay et al.,
2008; Nakayama et al., 2007). Thus, identifying the molecular in-
termediaries linking mitochondrial respiratory dysfunction with
mitochondria-triggered cell death is critical in advancing our
knowledge.
In the present study, we sought to elucidate the role of
impaired ETC function in the development of cardiac injury using
a mouse model with cardiac-specific deletion of Ndusf4 in com-
plex I of the ETC. Our results show that impaired ETC activity
due to decreased complex I function does not impair ATP sup-
ply or exacerbate ROS production under unstressed conditions.
However, complex I deficiency leads to NADH accumulation
and a decreased NAD+/NADH ratio, which inhibits Sirt3 activity
and results in protein hyperacetylation. In turn, this renders the
mice highly susceptible to additional stresses and accelerates
the development of heart failure after chronic increases of
workload.l Metabolism 18, 239–250, August 6, 2013 ª2013 Elsevier Inc. 239
Figure 1. Mouse Survival, Cardiac Function,
and Mitochondrial Assessment in Ndufs4-
Deficient Mice
(A) Fold changes ± SEM of ETC gene expression in
the cKO mice relative to CON (n = 7).
(B) Representative western blot for ETC proteins
(n = 4).
(C) Mitochondrial state 3 respiration in per-
meabilized cardiac fibers. Pyruvate + malate was
used as complex I substrate in the presence of
ADP, then succinate was added to establish
complex I + complex II (CI+CII) respiration, and,
finally, rotenone was added in order to block
complex I and establish complex II (CII) respiration
(mean ± SEM; n = 3).
(D–G) Kaplan-Meier survival curve of cKO and
CON mice (n = 19–25; D). Echocardiographic data
depicting fractional shortening (%; E), LV-end
diastolic dimension (mm; F), and posterior wall
thickness (mm; G) in CON (white) and cKO (black)
mice over 30 months (n = 6–13).
(H) Cardiac tissue citrate synthase enzyme activity
(n = 13–15). Data are expressed as means ± SEM.
*p < 0.05 versus CON.
(I and J) Electron microscopy images illustrating
mitochondrial arrangement and morphological
characteristic (I) and fold differences (J) in total
mitochondrial number. *p < 0.05 versus CON.
See also Figure S1 and Table S1.
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Deletion of Ndufs4 Reduced Complex I Assembly and
Function in Cardiac Mitochondria
Given that the global deletion of Ndufs4 leads to premature
death due to encephalopathy (Kruse et al., 2008), we deleted
Ndufs4 specifically in the heart in order to study the role of mito-240 Cell Metabolism 18, 239–250, August 6, 2013 ª2013 Elsevier Inc.chondrial dysfunction in cardiac function.
Cardiac-specific deletion of Ndufs4 (cKO)
in mice resulted in a more than 90% (p <
0.05) decrease of the Ndufs4 mRNA and
protein levels at 3–4 months of age in
the heart in comparison to littermate con-
trols (Ndufs4lox/lox, CON; Figures 1A–1B).
The expression of several complex I
genes, such as NDUFB6, NDUFB8, and
NDUFA9, remained unaltered at the
messenger RNA (mRNA) level but was
significantly reduced at the protein level.
In contrast, the complex II protein SDHB
remained unchanged in the cKO hearts.
The mRNA levels of several genes repre-
sentative of the ETC complexes II–IV
also remained unchanged (Figure 1A).
Furthermore, microarray analysis of the
cKO hearts did not reveal any significant
mRNA changes more than 1.5-fold (false
discovery rate < 0.05%) when compared
to CON hearts, except the Ndufs4
mRNA (Figure S1A available online). In-
gel complex I activity assays with bluenative gel (BNG) electrophoresis showed that complex I abun-
dance in the monomeric form as well as in the supercomplex as-
sembly was significantly reduced (Figure S1B). Furthermore,
lower-molecular-weight-band-bearing NADH dehydrogenase
activity was present in the cKO mitochondrial extracts, which
most likely represented the nonassembled or degraded product
of complex I. Thus, deletion ofNdufs4 in the heart did not change
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moted the degradation of complex I proteins. These data show
that Ndufs4 is essential for the assembly and/or stability of com-
plex I and that the loss of Ndufs4 protein resulted in a poorly
assembled and fragile complex I.
Complex activities measured in isolated submitochondrial
particles showed a75% (p < 0.05) decrease in complex I activ-
ity, whereas complex II and IV activities were not affected (Fig-
ure S1C). We also measured mitochondrial respiration and O2
consumption in permeabilized cardiac myofibers in order to
assess complex I function in the intact mitochondria. Complex
I-supported respiration was decreased by 45% (p < 0.05) in
the cKO myofibers, which was also reflected in the complex
III-supported respiration, whereas complex II-supported respira-
tion was not affected (Figure 1C). Similar decreases in complex I
activity and complex I-supported respiration were also observed
in cardiac mitochondria isolated from Ndufs4-null mice (global
deletion), suggesting that the deletion of theNdufs4 in cKO heart
is nearly complete (Figures S1D–S1E). Therefore, the lack of
Ndufs4 resulted in a substantial but incomplete loss of complex
I function in cardiac mitochondria. The greater impairment of
complex I activity detected in the submitochondrial particles of
cKO was most likely due to the instability of complex I, rendering
it more vulnerable to degradation during the isolation process.
Normal Lifespan and In Vivo Cardiac Function in Cardiac
Complex I-Deficient Mice
To determine the long-term effects of decreased complex I activ-
ity on the heart, we monitored survival and in vivo cardiac func-
tion in cKO mice by echocardiography every 6 months for
30 months. As shown in Figure 1D, despite the impairment of
complex I function, the cKO mice had a similar lifespan as the
CON mice. No significant difference was observed in fractional
shortening (FS%) or left ventricle (LV) chamber dimension at
any age in the cKO mice (Figures 1E–1F). We observed a small
but statistically significant increase in the LV posterior wall thick-
ness in the cKO mice at 18 and 24 months of age (Figure 1G).
Similar observations were made in both male and female mice
(Figures S1F–S1K). Tissue citrate synthase (CS) activity, a
commonly used marker of mitochondrial mass, was similar
between cKO and CON hearts (Figure 1H). Mitochondrial
morphology and number also appeared normal in the cKO hearts
in comparison to CON, as assessed by electron microscopy
(Figures 1I–1J). Thus, the significant complex I deficiency in
cKO did not affect survival, cardiac function, or mitochondrial
stereological characteristics in unstressed mice.
Maintained Myocardial Energetics and LV Performance
in cKO Hearts during Dobutamine Stimulation
To determine whether complex I deficiency affected ATP pro-
duction and myocardial energetics, we measured dynamic
changes of high-energy phosphate content using 31P nuclear
magnetic resonance (NMR) spectroscopy in isolated Langen-
dorff perfused hearts during dobutamine infusion. To test
whether substrate preference would affect these responses,
we perfused separate cohorts with a buffer containing primarily
glucose or mixed substrates (i.e., glucose, fatty acids, and
lactate). During baseline perfusion, the concentration of the
energy reserve compound, phosphocreatine (PCr), was slightlyCelhigher in cKO hearts perfused with a mixed substrate buffer (Fig-
ure 2A; p <0.05) andwas similar in CONand cKOhearts perfused
with glucose-based buffer (Figure S2A; p = .0958). The total cre-
atine content was not different (Figure S2I). No significant differ-
ences were noted in inorganic phosphate (Pi) or ATP concentra-
tions between the genotypes perfused with either substrate
mixture at baseline (Figures 2B–2C and S2B–S2C). At the end
of the dobutamine challenge, PCr and ATP decreased to the
same degree in both cKO and CON hearts perfused with either
buffer. Furthermore, Pi increased in cKO hearts after dobutamine
challenge with the mixed substrate buffer, and there was also a
trend for higher Pi with the glucose-based buffer. The change
in Pi reflected the higher amount of PCr in cKO at baseline, which
was depleted to the same level as CON during dobutamine chal-
lenge. Intracellular pH was constant throughout the perfusion
protocol (Figures 2D and S2D). Simultaneous assessment of car-
diac function revealed that LV-developed pressure and heart
rate (HR) were not statistically different in cKO and CON during
baseline perfusion regardless of the substrates supplied in the
perfusate (Figures 2E, 2F, and S2E–S2F). In response to dobut-
amine challenge, both cKO and CON had an equivalent 2-fold
increase in contractile performance assessed by rate-pressure
product, which was primarily accomplished by significant in-
creases in HR (Figures 2E–2G and S2E–S2G). Coronary flow
also remained similar during the course of the experiment be-
tween the two groups (Figures 2H and S2H). These observations
suggest that the cKO heart is able to maintain normal myocardial
energetics during baseline workload and is able to respond to
acute increases of workload demand while sustaining myocar-
dial energetics and contractile function.
Accelerated Heart Failure in cKO Mice in Response to
Chronic Stress
Next, we tested whether complex I deficiency would affect the
response to chronic cardiac stress. When we subjected mice
to pressure overload by transverse aortic constriction (TAC),
the cKO mice had an accelerated transition to heart failure (Fig-
ures 3A–3D). As early as 2 weeks after TAC surgery, the cKO
mice displayed a significant decrease in FS% and a significant
LV dilatation in comparison to CON mice. These changes per-
sisted at 4 weeks after TAC. Heart weight and lung wet weight,
indices of congestive heart failure, were increased in both geno-
types after TAC, but they were more prominent in the cKO mice
than the CON littermates (p < 0.05). To further confirm that this
effect was specific toNdufs4 deletion and not due to the overex-
pression of CRE recombinase in themousemodel, we subjected
a group of CRE-overexpressing mice to TAC surgery. CRE-over-
expressing mice had similar decreases in FS%, increases in LV
dimension, and heart weight as the CON-TACmice 4weeks after
TAC surgery, whereas these changes were exacerbated in the
cKO-TAC mice (Figures S3A–S3C), suggesting that the overex-
pression of CRE recombinase per se did not contribute to the
accelerated heart failure in this model.
Increased blood volume during pregnancy exerts volume
overload on the heart, causing physiological hypertrophy with
full postpartum recovery in healthy individuals. In control female
mice, we have not observed cardiac dysfunction due to repeated
pregnancies for up to a year. Surprisingly, after five to six gesta-
tion cycles, the cKO female mice developed cardiomyopathy,l Metabolism 18, 239–250, August 6, 2013 ª2013 Elsevier Inc. 241
Figure 2. Myocardial Energetics and Car-
diac Function in Isolated Perfused Hearts
(A–C) Phosphocreatine (PCr; A), ATP (B), and
inorganic phosphate (C) measured by 31P NMR
spectroscopy in isolated hearts perfused with
mixed substrate buffer during normal workload
and dobutamine challenge conditions.
(D) Intracellular pH calculated from the chemical
shift between PCr and Pi in isolated hearts
perfused with mixed substrate buffer during
normal workload and dobutamine challenge
conditions.
(E–G) LV-developed pressure (LVDevP; E), heart
rate (HR; F), and rate pressure product (RPP), the
product of LVDevP and HR (G), measured in iso-
lated hearts perfused with mixed substrate buffer
during normal workload and dobutamine chal-
lenge conditions.
(H) Coronary flow, estimated by collecting the
perfusate effluent over a 2 min period, in Lan-
gendorff heart preparations during normal work-
load and dobutamine challenge conditions (n = 5).
Data are expressed as means ± SEM. *p < 0.05
versus CON.
See also Figure S2.
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comparison to CON female mice that had gone through equal
numbers of pregnancy (Figures 3E–3I). Note that nulliparous fe-
male cKO mice had normal cardiac function at a similar age
(12 months old; Figure S1). These observations show that the
cKOmice are able tomaintain cardiac function under unstressed
conditions but are unable to adapt to chronic volume overload.
We also subjectedmice to a swim exercise for two 90min ses-
sions per day, 5 days per week, for a total of 4 weeks (Kregel
et al., 2006). We started with ten mice per group; seven CON
mice and eight cKO mice completed the study. At the end of
4 weeks of swim exercise, the heart weight and citrate synthase
enzyme activity in the gastrocnemious muscle were significantly
increased in both genotypes in comparison to the sedentary
groups (Figures S4A–S4B). As assessed by echocardiography,
cardiac function in vivo was decreased in the cKO mice, which
was accompanied by an increase in LV chamber size (Figures
S4C–S4D). Altogether, the results suggest that complex I func-
tion is essential for responding to chronic increases of workload
due to either pathological or physiological causes.
Complex I Deficiency Enhanced mPTP Sensitivity and
Increased Cell Death during Chronic Stress, which Was
Not Accounted for by Increased ROS Production
In cardiac tissue sections from cKO female breeders who had
developed cardiomyopathy, we found a 2-fold increase of
TUNEL-positive nuclei, increased fibrosis, and increased car-242 Cell Metabolism 18, 239–250, August 6, 2013 ª2013 Elsevier Inc.diac myocyte size in comparison to heart
sections from CON female mice with the
same number of breeding cycles (Figures
4A–4F). These results suggest that com-
plex I deficiency triggered cell death dur-
ing chronic stress. To determine whether
the cell death originated from abnormalopening of the mPTP, we isolated cardiac mitochondria from
cKO and CON mice and performed mitochondrial swelling and
Ca2+ uptake assays. Mitochondria from cKO hearts displayed
accelerated swelling in response to Ca2+ loading in comparison
to that from CON hearts, which was prevented by the addition of
the mPTP blocker, Cyclosporin A (CsA; Figure 4G). In a parallel
experiment, we also measured Ca2+ uptake and the induction
of the mPTP opening in isolated mitochondria. The mPTP open-
ing could be triggered in mitochondria from the cKO hearts by
a significantly lower amount of Ca+2 in comparison to CON
mitochondria, and the opening event was prevented in both ge-
notypes by the addition of CsA (Figure 4H). Collectively, these
findings suggest that mitochondria from the cKO heart are
more sensitive to Ca2+ challenge and more vulnerable to mPTP
opening and cell death.
Excessive ROS production has been previously suggested to
increase the mPTP sensitivity to Ca2+ challenge (Halestrap,
2010). Additionally, complex I dysfunction has been associated
with increased ROS production in the aging heart (Petrosillo
et al., 2009). However, H2O2 production was not increased in
the cKO mitochondria in comparison to CON under any of the
conditions we tested (Figure 5A). In contrast, we found that com-
plex I-mediated H2O2 production (by forward or reverse electron
flow through complex I) was decreased in the cKOmitochondria
in comparison to CON. Furthermore, we found that mitochon-
drial, but not cytosolic, H2O2 production was significantly
decreased in isolated cardiomyocytes from cKOwith fluorescent
Figure 3. Cardiac Function in Response to
Cardiac Stress
(A and B) Fractional shortening (A) and LV-end
diastolic dimension (B) before surgery (0 weeks)
and at 2 or 4 weeks after TAC or sham surgery in
male mice (#p < 0.05 versus the respective sham
group, and *p < 0.05 versus the CON-TAC group).
(C and D) Heart weight normalized to tibia length (C)
and lung edema index (D) at 4 weeks after TAC or
sham surgery (n = 5–6 sham, and n = 8–13 TAC).
(E–H) Average number of litters for female CON
and cKO mice (E), heart weight normalized to
body weight (F), and fractional shortening of these
mice (H; n = 9 CON, and n = 13 cKO; *p < 0.05
versus CON).
(I) Hematoxylin and eosin stain of a typical CON and
cKO heart after six gestational cycles. Data are
expressed as means ± SEM.
See also Figures S3 and S4.
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ments in cardiomyocytes (Figure 5B). Consistently, superoxide
level in cKO was also lower in permeabilized cardiomyocytes
both at baseline and after pyruvate, malate, and ADP (P/M/
ADP)-stimulated respiration (Figures 5C–5D). Aconitase activity,
which is sensitive to oxidative damage, was similar between theCell Metabolism 18, 239–2two genotypes (Figure 5E). In summary,
these data support the notion that, in
cKO hearts, complex I-dependent elec-
tron transport is decreased because of
decreased amounts of properly assem-
bled complex and not due to complex I
dysfunction (electron leakiness). We
found no evidence of increased ROS pro-
duction in cKO mitochondria. To further
exclude the possibility that the cKO hearts
had increased ROS production in vivo
during stress, we crossed cKO mice with
mice overexpressing mitochondria-tar-
geted catalase (mCat; Figure 5F). Overex-
pression of mCat has been previously
shown to protect against ROS damage
(Dai et al., 2009). However, the overex-
pression of mCat in the cKO mice did
not alter the course of heart failure
induced by TAC surgery (Figures 5G–5I).
Altogether, these findings show that
increased susceptibility to chronic stress
in cKO is independent of oxidative stress.
Complex I Deficiency Led to
Decreased NAD+/NADH Ratio,
Increased Protein Acetylation, and
Sensitized mPTP
Complex I is the major site for NADH
oxidation. Hence, we hypothesized that
decreased function of complex I would
result in NADH accumulation and an
altered redox state in the mitochondria ofthe cKO hearts. Indeed, NADH was significantly increased in
the cKO hearts with no change of NAD+ levels, resulting in a
50% decrease of the NAD+/NADH ratio (Figure 6A). There
were no changes in NADPH and NADP+ levels (Figure S5A).
The increase of the NAD pool was accompanied by an upregula-
tion in the expression of the rate-limiting enzyme in NAD50, August 6, 2013 ª2013 Elsevier Inc. 243
Figure 4. Increased Cell Death in the cKO
Hearts
(A–F) Representative image of TUNEL and DAPI
stain for apoptotic nuclei (A), trichrome stain for
fibrosis (B), and wheat germ agglutinin stain (C) to
outlining the cell surface area in female CON and
cKO mice after six gestational cycles and quanti-
tation graphs of those (D–F; n = 4 per group; *p <
0.05 versus CON).
(G) Mitochondrial swelling induced by Ca2+ pulsing
(25 mM [Ca2+] increments in the reaction buffer)
indicated by the black triangle measured as a
percent decrease in the initial optical density (OD
540) in the presence or absence of 1 mM CsA (this
experiment was repeated at least five times).
(H) Representative Ca2+ uptake traces by mito-
chondria in the presence or absence of 1 mM CsA.
Ca2+ was added to achieve 15 mM [Ca2+]
increments in the reaction buffer (this experiment
was repeated at least three times). Data are ex-
pressed as means ± SEM.
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a change in NAD+/NADH ratio would affect Sirt3 activity, we
tested the deacetylase activity of purified Sirt3 recombinant
protein supplemented with a fixed amount of NAD+ and variable
amounts of NADH. NADH exhibited a strong and dose-depen-
dent inhibition of Sirt3 activity despite the fact that NAD+ was
constant (Figure 6B). Similar inhibition by NADH was also
observed with Sirt2 (Figure S5C). Consistent with the finding
that Sirt3 activity was inhibited by a lower NAD+/NADH ratio,
we found that mitochondrial protein extracts from the cKO
hearts were hyperacetylated (Figures 6C–6D). Furthermore,
mitochondrial protein acetylation was also elevated in cKO
mice that developed heart failure due tomultiple gestation cycles
(Figures S5D and S5E). The protein levels of the three mitochon-
drial localized sirtuins, Sirt3, Sirt4, and Sirt5, were similar in cKO
and CON mitochondria (Figure S5F). Furthermore, the deacety-
lase activity of Sirt4 and Sirt5, if any, was several orders of
magnitude lower than that of Sirt3 (Figure S5G), suggesting
that the inhibition of Sirt3 activity by a lower NAD+/NADH ratio
rather than changes in the expression of sirtuins or the activity244 Cell Metabolism 18, 239–250, August 6, 2013 ª2013 Elsevier Inc.of Sirt4 and Sirt5 in the cKO was re-
sponsible for the increased acetylation.
We also immunoprecipitated acetylated
mitochondrial proteins from CON and
cKO mitochondria and blotted for the
known Sirt3 targets SOD2, NDUFA9,
and SDHA (Figure S6H). Acetylation of
NDUFA9 and SDHA was increased in
the cKO mitochondria, whereas SOD2
acetylation was unchanged, suggesting
that increased mitochondrial protein
acetylation occurred in a subgroup of
Sirt3 substrates in the cKO hearts. Over-
expression of Sirt3 in cKO cardiac myo-
cytes normalized the protein acetylation
status (Figures 6E and 6F) as well as the
sensitivity of mPTP opening (Figures 6G
and 6H).Next, we sought to alter the mitochondrial protein acetylation
status by manipulating the NAD+/NADH ratio both in vitro and
in vivo. First, we measured NADH fluorescence during different
respiratory states in isolated cKO mitochondria (Figure 7A).
NADH was increased in state 2 respiration with glutamate and
malate (G/M) when NADH production was high relative to the
ETC flux. The transition to state 3 after the addition of ADP
reduced the NADH levels because NADH was utilized for ATP
synthesis. The addition of rotenone blocked complex I activity
and increased the NADH levels. On the basis of this observation,
we were able to reduce mitochondrial protein acetylation by pre-
treatment of mitochondria with ADP, and we increased protein
acetylation by adding G/M or rotenone and nicotinamide
(NAM; Figures 7B and 7C). NAM is a potent inhibitor of Sirt3
activity in isolated mitochondria and was used as a positive con-
trol (Avalos et al., 2005). Simultaneous measurements of mito-
chondria calcium uptake and retention capacity showed that
the sensitivity of the mPTP opening to calcium challenge fol-
lowed the changes in the protein acetylation status (Figures 7D
and 7E). To test the hypothesis in vivo, we sought to normalize
Figure 5. ROS Production Is Not Increased in the cKO Hearts
(A and B) Measurement of H2O2 production using Amplex Red in isolated
cardiac mitochondria from CON (white) and cKO (black) mice treated with
pyruvate and malate (10/5 mM; P/M), succinate (10 mM, S), rotenone (10 mM,
Rot), Antimicyn A (1 mg/ml, AntA), ADP (2.5 mM), or combinations of those (A;
n = 4) and mitochondrial or cytosolic H2O2 production in isolated car-
diomyocytes using a fluorescent probe targeted to mitochondria (Mito-Hyper)
or to cytosol (B; Cyto-Hyper; n = 27-43; *p < 0.05 versus CON).
(C) Data showing the change of MitoSOX fluorescence at 405 nm excitation
during a 5 min period before () or after the addition of respiration substrates
(P/M/ADP). Data are expressed as mean ± SEM (n = 9–10 cells from 2–3 mice;
#p < 0.05 P/M/ADP versus nontreated, and *p < 0.05 cKO versus CON).
(D) Representative images of CON and cKO permeabilized cardiomyocytes
showing the MitoSOX fluorescence at 5 min after the addition of respiration
substrates (10 mM pyruvate, 5 mM malate, and 2 mM ADP).
(E) Cardiac tissue aconitase enzyme activity (n = 3). Data are expressed as
means ± SEM.
(F) Representative western blot for mitochondrial catalase in hearts from CON,
cKO, and cKO-mCat mice.
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Celthe NAD+/NADH ratio by treating the cKOmicewith nicotinamide
mononucleotide (NMN), an NAD precursor that has previously
been shown to increase intracellular NAD+ levels (Yoshino
et al., 2011). NMN supplementation for 3 days increased the
NAD+/NADH ratio in the cKO hearts, decreased the mitochon-
drial protein acetylation, and improved the sensitivity of the
mPTP in the cKOmitochondria (Figures 7F–7I). Altogether, these
results established a strong link between NAD+/NADH ratio,
mitochondrial protein acetylation, and mPTP sensitivity, con-
necting the respiratory function of mitochondria to cell survival
via protein acetylation.
DISCUSSION
We demonstrate that the deletion of Ndufs4 results in a signifi-
cant loss of complex I-supported respiration in the heart, which
is well tolerated with no major changes of cardiac function, ener-
getics, and longevity of the mice under unstressed conditions.
However, complex I deficiency increases protein acetylation by
altering the redox state and renders the heart vulnerable to cell
death and heart failure during chronic increases of workload.
These findings describe a mechanism by which impaired mito-
chondrial complex I function predisposes the myocardium to
injury via altered protein acetylation and susceptibility to chronic
stress.
Deletion of Ndufs4 resulted in a drastic reduction of complex I
activity in submitochondrial particles, whereas mitochondrial
respiration with complex I substrates in permeabilized cardiac
myofibers was less affected. The dissociation between complex
I-supported respiration and its enzymatic activity in sub-
mitochondrial particles has been previously reported in liver
mitochondria from the Ndufs4-null mice as well as in mouse
embryonic fibroblast (MEF) cells from the same mice (Kruse
et al., 2008; Valsecchi et al., 2012). Our study shows that the
deletion of Ndufs4 resulted in the degradation of multiple pro-
teins in complex I and a failure to assemble supercomplexes,
suggesting that Ndufs4 is critical for complex I assembly and
stability. The ‘‘loosely’’ assembled complex I in the absence of
Ndufs4 makes it more vulnerable to mechanical dissociation
during the isolation of submitochondrial particles, thus exagger-
ating the decrease of complex I activity. Using complex I-sub-
strate-supported respiration in the intact mitochondria as a
measurement of respiratory capacity, we have determined that
cardiac mitochondria of the cKO have approximately 50% of
the normal complex I function.
Despite the decrease in complex I function, we did not
observe any impairment in cardiac function or energetics in iso-
lated isovolumic hearts from the cKO mice. Although, the work-
load of an isovolumic perfused heart experiments is lower than
in vivo conditions, the heart responds normally to dobutamine
stimulation by increasing contractile performance while sustain-
ing myocardial high-energy phosphate content. A similar
decrease in complex I function but normal cardiac function(G–I) Heart weight normalized to tibia length(G), fractional shortening (H), and
LV end diastolic dimension (I) at 4 weeks after TAC or sham surgery (n = 11 for
the cKO-mCat TAC group, and n = 5 for the rest of the groups). Data are ex-
pressed as means ± SEM. *p < 0.05 versus the respective sham, indicated by
the dotted line, and #p < 0.05 versus CON-TAC.
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Figure 6. NAD+/NADH Regulates Mitochon-
drial Protein Acetylation via SIRT3
(A) NADH and NAD+ concentrations in freeze-
clamped mouse hearts from CON and cKO mice
(n = 5).
(B) Sirt3 activity assay with a 3 mM of NAD+ and
0–9 mM of NADH.
(C and D) Representative blot for acetylated lysine
residues (Ac-K) and VDAC (loading control; C), and
a quantitation graph in cardiac mitochondrial
extracts (D; n = 4; the vertical line in C indicates
the area on the blot used for quantitation).
(E and F) Western blot (E) and a quantitation graph
(F) of Ac-K residues in isolated cardiomyocytes
from CON and cKO hearts overexpressing Sirt3.
SIRT3 protein levels and SDHA (loading control)
are also shown (n = 3).
(G) Representative linescan confocal images
showing the laser induced mPTP opening in
cultured adult cardiac myocytes as reflected by
the sudden loss of membrane potential (TMRM,
red).
(H) Summarized data showing the time from the
start of scan to the mPTP opening (mPTP time).
The shorter the time, the more sensitive mPTP is.
n = 120–143 mitochondria from 21–25 cells iso-
lated from three hearts in each group. All data are
expressed as means ± SEM. *p < 0.05 versus Con,
and #p < 0.05 versus without AdSirt3.
See also Figures S5.
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Complex I Deficiency Increases Protein Acetylationunder unstressed conditions has also been reported in the
Ndufs4 KO mice by a different group (Sterky et al., 2012). The
same group also reported that MEF cells from Ndufs4-deficient
mice had a >50% decrease in complex I-supported respiration,
but the ATP production was not affected (Valsecchi et al., 2012).
Thus, cardiac tissue has a remarkable reserve in complex I-
dependent ATP synthesis and is able to tolerate a substantial
loss of the function without affecting energetics in unstressed
mice. This is in contrast to the brain, where a similar impairment
of complex I function lead to severe neurological defects and the
premature death in Ndufs4-null mice (Kruse et al., 2008; Quin-
tana et al., 2010).
Complex I is a major source for mitochondrial ROS production
in the ETC, and certain pathological conditions have been shown
to further enhance mitochondrial ROS production (Liu et al.,
2002; McLennan and Degli Esposti, 2000). Dysfunctional com-
plex I can generate more ROS because of the ‘‘leakiness’’ in
the ETC. However, this ismost likely not the case inmitochondria
lacking Ndufs4, which, on the basis of our assessment, produce
less superoxide or H2O2 under conditions of either forward or246 Cell Metabolism 18, 239–250, August 6, 2013 ª2013 Elsevier Inc.reverse electron flow. Moreover, overex-
pression of a potent antioxidant, catalase,
targeted to mitochondria did not improve
the response to pressure overload in cKO
mice. Although our study has not as-
sessed every type and source of ROS,
the results suggest that the pathogenic
mechanisms for heart failure in this model
are unlikely to be attributable to increased
oxidative stress. These findings also sup-port the notion that the deletion of Ndufs4 resulted in a loss of
function rather than a dysfunctional complex I.
Although the complex I capacity is in excess for normal
myocardial energetic demand at basal state, it is essential for
maintaining mitochondrial redox state and for adaptation to
chronic stress. The present study shows that complex I defi-
ciency decreases the NAD+/NADH ratio and impairs protein
deacetylation. Changes in NAD+/NADH ratio have been increas-
ingly recognized as important regulatory mechanisms of physio-
logical functions and diseases. For example, an increasedNAD+/
NADH ratio has been proposed to be an important mechanism
mediating the beneficial effects of caloric restriction in health
and longevity (Lin et al., 2004). In contrast, decreased NAD+/
NADH ratio has been observed in diabetes and obesity and pro-
posed as a disease mechanism (Ido, 2007). NAD+ is a substrate
for the class III NAD+-dependent deacetylase sirtuins and a
powerful activator of the sirtuin activity (Avalos et al., 2005).
Here, we found that Sirt2 and Sirt3 activities were both inhibited
with increasing NADH concentrations at a fixed amount of NAD+.
Competitive inhibition of the yeast Sir2 activity by NADH has also
Figure 7. Regulation of the mPTP by Mito-
chondrial NADH and Protein Acetylation
(A) Representative NADH autofluorescence trace
with isolated mitochondria stimulated with gluta-
mate and malate (G/M; 10/5 mM), ADP (250 mM),
or Rot (1 mM) added consecutively in this order in
the same trace.
(B–E) A representative western blot (B) and a
quantitation graph (C) for Ac-K residues in protein
extracts of CON and cKOmitochondria pretreated
separately with G/M (10/5 mM), ADP (250 mM), Rot
(1 mM), or nicotinamide (NAM; 10mM) for 20min at
30C (the vertical line in B indicates the area on the
blot used for quantitation). SDHA was used as a
loading control. *p < 0.05 versus CON nontreated,
and #p < 0.05 versus cKO nontreated mice.
Representative Ca2+ uptake traces from CON (D)
and cKO (E) mitochondria isolated in the presence
or absence of G/M (10/5 mM), ADP (250 mM), Rot
(1 mM), or NAM (10 mM). Each experiment was
repeated at least three times.
(F) NAD+/NADH ratio in freeze-clamped mouse
hearts from CON and cKO mice treated with
vehicle or cKO treated with nicotinamide NMN as
described in the Experimental Procedures (n = 3).
(G) Representative western blots for Ac-K residues
and VDAC (loading control) in CON and cKO car-
diac mitochondria from mice treated with vehicle
or NMN.
(H and I) Ca2+ uptake traces (H) and quantitation
graph (I) from cardiac mitochondria isolated from
CON and cKO mice treated with vehicle or NMN.
Data in (F) and (I) are expressed as means ± SEM.
*p < 0.05 versus CON-Veh, and #p < 0.05 versus
cKO-Veh.
Cell Metabolism
Complex I Deficiency Increases Protein Acetylationbeen previously shown (Lin et al., 2004). Among the seven mem-
bers of the sirtuin family, Sirt3 is specifically localized to mito-
chondria and has emerged as a major regulator of mitochondrial
protein acetylation, whereas two other mitochondria-localized
sirtuins, Sirt4 and Sirt5, have minimal deacetylase activity (Du
et al., 2011; He et al., 2012; Lombard et al., 2007). Because
the protein level of Sirt3, Sirt4, and Sirt5 is unaltered, our results
suggest that the inhibition of Sirt3 activity by a low NAD+/NADH
ratio causes mitochondrial protein hyperacetylation in complex
I-deficient cardiac tissue. In support of this, restoration of the
NAD+/NADH ratio by NMN reduced mitochondrial protein acet-
ylation in the cKO hearts.
The NAD+/NADH ratio has been suggested to modulate the
opening of the mPTP. NADH has been shown to bind to VDAC,
which is an important regulator of the mPTP and alters the
permeability of the mitochondrial outer membrane (Halestrap,
2010; Zizi et al., 1994). Recent studies have demonstrated that
increased mitochondrial protein acetylation due to Sirt3 deletion
is associated with increased sensitivity of mPTP opening (HafnerCell Metabolism 18, 239–25et al., 2010; Shulga and Pastorino, 2010;
Shulga et al., 2010). Mice lacking Sirt3
have normal cardiac function but are sen-
sitive to cardiac stress, resembling the
observations reported here in mice with
complex I deficiency in the heart (Hafner
et al., 2010; Shulga and Pastorino, 2010;Shulga et al., 2010). In Sirt3 knockout mice, one study attributed
increased cell death during stress to the hyperacetylation of
cyclophilin D and increased vulnerability of mPTP opening. How-
ever, we failed to observe the hyperacetylation of cyclophilin D in
Ndufs4 cKO mice. Similarly, the acetylation of SOD2 did not
change in cKO mice but increased significantly in Sirt3-null
mice. These observations suggest that the inhibition of sirtuin
activity due to impaired mitochondrial function, unlike the dele-
tion of Sirt3, does not uniformly affect its targets. However, other
Sirt3 targets, such asNDUFA9 andSDHA, are hyperacetylated in
cKO hearts. Moreover, the overexpression of Sirt3 corrected
protein hyperacetylation and mPTP sensitivity in cKO cardio-
myocytes. The evidence collectively suggests that increased
mitochondrial protein acetylation is a common mechanism for
the impaired response to cardiac stress. Furthermore, we have
demonstrated that decreased NAD+/NADH ratio and increased
mitochondrial protein acetylation is causally linked to increased
sensitivity of mPTP during calcium challenge. However, it
remains to be determined whether it is the hyperacetylation of0, August 6, 2013 ª2013 Elsevier Inc. 247
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increased sensitivity to cardiac stress. The similarities in the car-
diac phenotype between the Ndufs4 cKO and the Sirt3 KO mice
are intriguing, but additional discrete mechanisms may also
contribute to the phenotype.
In summary, the study identifies a mechanism that links mito-
chondrial respiratory function with protein modification and
a cell-death mechanism. The findings indicate that complex
I-dependent respiratory capacity is in excess of normal demand
in cardiac mitochondria and is partially dispensable for ATP pro-
duction. However, it is a critical regulator of the redox balance in
the mitochondria, which is indispensable for cardiac response to
chronic stress.
EXPERIMENTAL PROCEDURES
Animal Experiments and Generation of Ndufs4 KO Mice
All animal experiments were performed with the approval of the Institutional
Animal Care and Use Committee of the University of Washington. Mice were
maintained on rodent diet and water available ad libitum in a vivarium with a
12 hr light/dark cycle at 22C. To generate a cardiac-restricted, complex
I-deficient mouse, we crossed C57BL6 mice bearing the modified ndufs4
gene containing loxP sites with transgenic C57BL6 mice expressing the
enzyme CRE recombinase driven under the aMHC promoter. To generate
cKO-mCatmice, we crossed cKOmicewith transgenic C57BL6mice express-
ing the enzyme catalase targeted to mitochondria also driven under the aMHC
promoter. For the nicotinamide NMN experiment, mice at4 months old were
intraperitoneally administered with NMN (Sigma-Aldrich) at 500mg/kg twice in
3 days. The hearts were harvested for mitochondria isolation and subsequent
assays 24 hr after the last injection. Detailed procedures for transverse aortic
constriction, swimming exercise, and echocardiography can be found in the
Supplemental Experimental Procedures.
Mitochondrial Isolation
Mitochondria were isolated as previously described (Boehm et al., 2001).
Polarography Assays
Oxygen consumption of permeabilized cardiac myofibers by a Clark electrode
was performed as previously described (Kuznetsov et al., 2008). Procedures
are described in detail in the Supplemental Experimental Procedures.
Determination of mRNA and Protein Levels and
Immunoprecipitation
The isolation of total RNA,microarray analysis, real-time PCR, and immunoblot
were described in the Supplemental Experimental Procedures. Immunopre-
cipitation experiments were performed with prewashed agarose coupled
with an antibody against acetyl-lysine (ImmuneChem). Detailed descriptions
can be also found in the Supplemental Experimental Procedures.
Biochemical Assays
Enzyme activities were measured in isolated mitochondria solubilized in Cel-
lytic buffer (Sigma-Aldrich). CS and complex I, II, and IV enzyme activities
were measured as previously described (Kerner et al., 2001; Ro¨ckl et al.,
2007; Yen et al., 1999). The NAD+/NADH as well as NADP+/NADPH ratios
were measured with commercially available kits (BioAssay Systems). The aco-
nitase enzyme activity was measured with an Aconitase Assay Kit (Cayman
Chemical) according to manufacturer’s instructions. The total creatine level
was measured as previously described (Tian et al., 1996). The activity of
Sirt3, Sirt4, and Sirt5 in vitro was determined as described in the Supplemental
Experimental Procedures.
Histology and Electron Microscopy
An in-depth description of the procedures of histology and electron micro-
scopy of heart tissues is available in the Supplemental Experimental
Procedures.248 Cell Metabolism 18, 239–250, August 6, 2013 ª2013 Elsevier IncBlue Native Gel Electrophoresis and Complex I In-Gel Activity
Staining
BNG experiments were performed as previously described (Suthammarak
et al., 2009; Wittig et al., 2006) with minor modifications. Procedures are
described in detail in the Supplemental Experimental Procedures.
Detection of H2O2 and Superoxide Production
The rate of H2O2 production in intact mitochondria was determined with the
oxidation of the fluorogenic indicator Amplex Red in the presence of horse-
radish peroxidase (Moghaddas et al., 2003). In a typical experiment, 30 mg
of mitochondria in a 96-well plate were incubated at 30C, and H2O2 produc-
tion was initiated in mitochondria by the addition of the substrates indicated in
Figure 5.
Formeasurements of H2O2 production in intact cells, freshly isolated cardiac
myocytes were plated on 25 mm coverslips coated with laminin (20 mg/ml) for
2 hr in order to allow for cell attachment. Attached myocytes were infected
with adenovirus carrying Hyper (Cyto-Hyper, indicates cytosolic hydrogen
peroxide) or mitochondria-targeted Hyper (Mito-Hyper, indicates mitochon-
drial hydrogen peroxide) at a multiplicity of infection of 100. Myocytes were
cultured in M199 medium (Sigma-Aldrich) supplemented with 0.02% BSA,
5 mM creatine, 2 mM L-carnitine, 5 mM taurine, 5 mM HEPES, and insulin-
transferrin-selenium X. Myocytes were kept in culture for 48 hr in order to allow
adequate indicator expression prior to imaging. The basal level of cell Mito-
Hyper or Cyto-Hyper was the average fluorescence ratio (488:405) of the first
ten images.
For superoxide measurements, isolated cardiomyocytes were loaded with
MitoSOX red (5 mM for 10 min) and then permeabilized with saponine
(50 mg/ml). Sequential two-dimensional confocal images were taken at 405 nm
excitation, and emission was collected at >560 nm. Respiration was stimulated
byadding10mMpyruvate, 5mMmalate, and2mMADPafter thebaseline scan.
To calculate the rate of MitoSOX signal change (dF/dt), fluorescent signals dur-
ing a 5 min period before or after the respiration stimulation was used.
Mitochondrial Swelling and Ca2+ Uptake Assays
Mitochondrial swelling was induced in cardiac isolated mitochondria as previ-
ously described with minormodifications (Wang et al., 2005). In brief, 200 mg of
mitochondria were incubated in a 96-well plate with 10mMof succinate with or
without 1 mM of CsA or 1 mM rotenone in 200 ml of swelling buffer (containing
120 mM KCl, 10 mM Tris-HCl [pH 7.4], 20 mM MOPS, and 5 mM KH2PO4) at
30C. Swelling was initiated by the addition of 25 mM Ca2+ and measured
spectrophotometrically as a reduction in absorbance at 540 nm.Mitochondrial
Ca2+ uptake assays were performed as previously described in order to deter-
mine the Ca2+ retention capacity (Marcu et al., 2012).
Overexpression of Sirt3 and Assessment of mPTP Sensitivity in the
Intact Cardiomyocytes
Determination of mPTP sensitivity in intact myocytes followed previously re-
ported methods (Zorov et al., 2000). A detailed description is available in the
Supplemental Experimental Procedures.
Isolated Perfused Mouse Heart Preparation and 31P NMR
Spectroscopy
To assess left ventricular function and energetics, we combined Langendorff
isolated heart preparations with 31P NMR spectroscopy (Kolwicz and Tian,
2010; Luptak et al., 2007; Yan et al., 2009). Procedures are described in detail
in the Supplemental Experimental Procedures.
Statistical Analysis
Comparisons among the groups were performed by one-way ANOVA followed
by Tukey’s post hoc comparisons. All analyses were performed with Graph-
Pad Prism 4.0. All data are expressed as mean ± SEM, and a p < 0.05 was
considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2013.07.002..
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